OakChart

Myomo Inc

MYOHealthcare·Medical Devices·USA·Micro·AMEX·Nov 11 • 3:09 PM ET

1.26-0.00 (-0.39%)
2026-11-11 21:09 CET
Market cap
50.30 USD m
Revenue, TTM
45.50 USD m
Net income, TTM
-15.08 USD m
Free cash flow, TTM
-5.76 USD m
EPS diluted, TTM
-0.35
P/E
-
Compare

Price

MYO against its 20, 50 and 200-day averages
2050200beatmiss
1.001.502.5M5.1MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26MYOclose 1.2720-day 1.2550-day 1.37200-day 1.091.2752w high

32.9% under the 52-week high of 1.89 on 19 Aug 2026. 52-week low 0.61 on 31 Mar 2026. Last 15 sessions, 26.7% high to low

Volume 0.41× normal · the line is the 50-bar volume average

Profile

MYO
52-week range, 51% of the way up
0.611.88

Myomo, Inc. is a wearable medical robotics company, which engages in the business of developing, designing, and producing myoelectric orthotics for people with neuromuscular disorders. It is also involved in selling products through various other sales channels including through orthotics and prosthetics providers, veterans' administration, and to distributors in certain accounts and geographic markets. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Burlington, MA.

Employees195
IPOJun 12, 2017
Beta1.70
ATR, 14d0.12
Rel volume0.41
Short float3.26%
Insider own10.45%
Inst own34.72%

Snapshot

6 groups

Valuation

Index-
Market Cap50.73M
Enterprise Value60.19M
Income-15.08M
Sales45.50M
Book/sh0.07
Cash/sh0.30
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees195
IPOJun 12, 2017

Ratios

P/E-
Forward P/E-
PEG-
P/S1.11
P/B18.42
P/C4.25
P/FCF-
EV/EBITDA-
EV/Sales1.32
Quick Ratio1.66
Current Ratio1.92
Debt/Eq7.79
LT Debt/Eq6.83
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.35
EPS next Y-0.20
EPS next Q-0.06
EPS this Y12.97%
EPS next Y38.51%
EPS next 5Y34.81%
EPS past 3/5Y37.45% 36.74%
Sales past 3/5Y38.05% 40.10%
EPS Y/Y TTM-22.32%
Sales Y/Y TTM9.27%
EPS Q/Q-11.85%
Sales Q/Q22.20%
EarningsNov 09 AMC
EPS/Sales Surpr.-28.21% 7.13%

Ownership

Insider Own10.45%
Insider Trans4.32%
Inst Own34.72%
Inst Trans-1.48%
ROA-44.42%
ROE-173.54%
ROIC-70.01%
Gross Margin70.15%
Oper. Margin-21.78%
Profit Margin-33.14%
SMA201.26%
SMA50-7.89%
SMA20015.98%
Trades-

Technical

Shs Outstand40.05M
Shs Float35.47M
Short Float3.26%
Short Ratio2.81
Short Interest1.16M
52W High1.88 -32.89%
52W Low0.61 109.09%
Volatility11.91% 8.80%
ATR (14)0.12
RSI (14)47.67
Beta1.70
Rel Volume0.41
Avg Volume412.05K
Volume149,438

Performance

Perf Week-2.69%
Perf Month-1.94%
Perf Quarter-13.36%
Perf Half Y55.58%
Perf YTD39.01%
Perf Year48.82%
Perf 3Y-40.61%
Perf 5Y-86.78%
Perf 10Y-
Recom1.00
Target Price4.64
Prev Close1.27
Price1.26
Change %-0.39%

Analyst ratings

latest 6 of 6
DateActionAnalystRating changeTargetImplied
Jul 31, 2024InitiatedCCraig HallumBuy$7+453.4%
May 20, 2024InitiatedLLake StreetBuy$7+453.4%
Dec 15, 2023InitiatedHH.C. WainwrightBuy$6.50+413.8%
Nov 11, 2020UpgradeRROTH CapitalNeutral → Buy$5 → $7+453.4%
May 27, 2020InitiatedDDougherty & CompanyBuy$8.50+571.9%
Oct 02, 2017InitiatedHH.C. WainwrightBuy$12+848.6%

Peers

Mkt cap
TickerCompanyMkt cap
LFWDLifeward Ltd16.37M
MBOTMicrobot Medical Inc73.54M
TNONTenon Medical Inc4.73M
NXLNexalin Technology Inc1.82M
MODDModular Medical Inc16.52M
IRIXIRIDEX Corp12.56M
NVNOenVVeno Medical Corp4.59M
VVOSVivos Therapeutics Inc3.15M
NUWENuwellis Inc2.99M
ICCMIcecure Medical Ltd2.63M

Insider trading

latest 14 of 31
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
David HenryOfficerOct 12 '26Proposed Sale1.373,1334,292Oct 13 09:27 AM
Kovelman HarryChief Medical OfficerSep 11 '26Sale1.2715,48819,68490,245Sep 14 04:30 PM
HARRY KOVELMANOfficerSep 11 '26Proposed Sale1.2715,84420,136Sep 11 04:37 PM
Morris Milton MayoDirectorSep 02 '26Sale1.4115,00021,150208,391Sep 04 04:30 PM
Morris Milton MayoDirectorSep 02 '26Proposed Sale1.4115,00021,150Sep 02 03:06 PM
Kovelman HarryChief Medical OfficerAug 20 '26Sale1.7317,25029,896105,983Aug 21 06:17 PM
HARRY KOVELMANOfficerAug 20 '26Proposed Sale1.7317,50030,329Aug 20 04:04 PM
David HenryOfficerJul 13 '26Proposed Sale1.095,1665,631Jul 13 04:29 PM
Harry KovelmanOfficerJun 12 '26Proposed Sale1.2010,44212,530Jun 12 04:17 PM
Micah MitchellOfficerJun 12 '26Proposed Sale1.209,06110,873Jun 12 04:16 PM
KIRK THOMAS FDirectorJun 05 '26Buy1.2740,00250,803693,865Jun 09 04:07 PM
Harry KovelmanOfficerJun 08 '26Proposed Sale1.337,63510,155Jun 08 04:12 PM
Micah MitchellOfficerJun 08 '26Proposed Sale1.336,5298,684Jun 08 04:10 PM
KIRK THOMAS FDirectorMay 28 '26Buy0.9925,00024,825653,863Jun 01 08:23 AM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-09-0.100-0.078-0.10012.3311.515
2026Q22026-08-05-0.090-0.098-0.09411.7010.355
2026Q12026-05-07-0.070-0.114-0.07110.119.245
2025Q42026-03-09-0.090-0.086-0.09011.3510.405
2025Q32025-11-10-0.090-0.108-0.08710.099.445
2025Q22025-08-11-0.110-0.106-0.1119.659.155
2025Q12025-05-07-0.080-0.076-0.0849.839.225
2024Q42025-03-10-0.010-0.023-0.00712.079.906
2024Q32024-11-06-0.030-0.042-0.0269.218.116
2024Q22024-08-06-0.030-0.070-0.0307.526.706
2024Q12024-05-08-0.100-0.097-0.1043.754.073
2023Q42024-03-07-0.070-0.058-0.0704.764.894
2023Q32023-11-07-0.060-0.090-0.0585.084.164
2023Q22023-08-09-0.040-0.033-0.0365.965.634
2023Q12023-05-10-0.110-0.135-0.1093.453.334
2022Q42023-03-13-0.290-0.418-0.2954.044.064

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-19.350-19.353-20.7853.843.63
2020FY-3.670-3.765-3.6747.586.81
2021FY-1.890-1.866-1.88913.8612.81
2022FY-1.520-1.620-1.52015.5615.57
2023FY-0.280-0.258-0.27619.2419.38
2024FY-0.160-0.180-0.16432.5530.39
2025FY-0.370-0.366-0.37040.9339.99
2026FY--0.322--46.05
2027FY--0.198--51.10
2028FY--0.103--58.79
2029FY-0.200--77.08
2030FY-0.450--94.95

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-1050112.2111.6012.50
2026Q4S2026-11-0950012.2811.6012.72
2026Q4S2026-11-0850012.2811.6012.72
2026Q4S2026-10-2050112.2811.6012.72
2026Q4S2026-08-2550312.2811.6012.72
2026Q4S2026-08-1950212.4412.1112.72
2026Q4S2026-08-0650312.4412.1112.72
2026Q4S2026-07-2250112.8212.4013.98
2026Q4S2026-06-0551312.8212.4013.98
2026Q4S2026-05-2451212.9612.4913.98
2026Q4S2026-05-0852212.9612.4913.98
2026Q4S2026-03-1051313.0212.3014.00
2026Q4S2026-02-0350013.0910.2014.07
2026Q4S2026-01-3150113.0910.2014.07

Estimate history

EPS, annual-87.9-25.178-20.785-3.674-1.889-1.52-0.276-0.164-0.372-0.3529
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.026-0.007-0.084-0.111-0.087-0.09-0.071-0.094-0.097
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual1.5592.4443.8387.58313.85615.55519.24132.55140.92845.5
Period201720182019202020212022202320242025TTM
Sales, quarterly9.20812.0689.8329.65210.09111.35310.11311.70512.331
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual0.3710.4150.5754.5936.877.75127.13534.37838.47140.047
Period201720182019202020212022202320242025MRQ
Shares, quarterly30.24434.37834.43837.7838.43338.47138.56639.53540.047
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue45.5040.9332.5519.2415.5613.867.583.842.44
Cost of Goods Sold Incl. D&A13.5814.049.376.065.303.542.601.420.73
Gross Profit31.9226.8923.1913.1810.2510.314.982.421.72
Selling, General and Administrative Excl. Other41.8341.2929.3921.4120.9320.5815.4913.2112.24
Research and Development6.786.944.772.642.482.561.671.751.84
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-9.91-14.40-6.21-8.23-10.67-10.27-10.50-10.79-10.53
Interest Expense2.340.930.000.000.000.000.220.110.00
Unusual Expense2.420.220.000.000.000.000.59-0.19-0.04
Net Income Before Taxes-14.67-15.07-5.82-7.99-10.65-10.28-11.56-10.71-10.32
Income Taxes0.410.500.370.160.070.090.000.000.00
Consolidated Net Income-15.08-15.57-6.18-8.15-10.72-10.37-11.56-10.71-10.32
Net Income From Continuing Operations-15.08-15.57-6.18-8.15-10.72-10.37-11.56-10.71-10.32
Net Income-15.08-15.57-6.18-8.15-10.72-11.01-12.23-11.51-10.32
EPS (Recurring)-0.31-0.37-0.16-0.28-1.52-1.89-3.55-21.03-25.24
EPS (Basic, Before Extraordinaries)-0.35-0.37-0.16-0.28-1.52-1.89-3.67-20.79-25.18
EPS (Diluted)-0.35-0.37-0.16-0.28-1.52-1.89-3.67-20.79-25.18
EBITDA-7.82-12.64-5.43-7.71-10.13-9.93-10.39-10.70-10.46
Non-Operating Income (Expense)0.000.480.390.240.02-0.02-0.260.000.18
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.781.650.690.880.941.100.610.910.81
Price To Sales Ratio1.490.937.477.680.232.882.961.307.24
Gross Margin70.1565.7071.2368.5165.9174.4265.7162.9870.20
Operating Margin-21.78-35.19-19.07-42.78-68.61-74.10-138.50-281.29-430.77
Net Margin-33.14-38.05-19.00-42.34-68.92-79.47-161.33-299.93-422.11
Shares Outstanding40.0538.4734.3827.147.756.874.590.570.41
Market Capitalization50.3050.30214.10132.853.6146.9630.845.1817.93

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue12.3311.7010.1111.3510.099.659.8312.07
Cost of Goods Sold Incl. D&A3.543.263.213.573.653.603.223.45
Gross Profit8.798.446.907.786.446.056.618.62
Selling, General and Administrative Excl. Other10.5110.7010.0610.569.9610.6410.138.86
Research and Development1.811.721.621.621.532.001.791.56
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-1.72-2.25-3.16-2.77-3.52-4.59-3.52-0.25
Interest Expense0.560.540.500.740.01-0.000.00
Unusual Expense1.851.20-0.840.220.000.000.000.00
Net Income Before Taxes-4.13-3.99-2.82-3.73-3.53-4.48-3.33-0.18
Income Taxes0.100.030.190.080.140.150.140.08
Consolidated Net Income-4.23-4.02-3.01-3.81-3.66-4.63-3.47-0.26
Net Income From Continuing Operations-4.23-4.02-3.01-3.81-3.66-4.63-3.47-0.26
Net Income-4.23-4.02-3.01-3.81-3.66-4.63-3.47-0.26
EPS (Recurring)-0.07-0.07-0.09-0.09-0.09-0.11-0.08-0.01
EPS (Basic, Before Extraordinaries)-0.10-0.09-0.07-0.09-0.09-0.11-0.08-0.01
EPS (Diluted)-0.10-0.09-0.07-0.09-0.09-0.11-0.08-0.01
EBITDA-1.13-1.69-2.69-2.32-3.08-4.16-3.070.22
Non-Operating Income (Expense)0.000.000.000.000.000.110.190.07
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.040.820.470.450.460.310.430.25
Price To Sales Ratio1.491.030.690.940.902.205.167.70
Gross Margin71.2972.1368.2468.5663.8462.7067.2371.39
Operating Margin-13.98-19.26-31.22-24.43-34.86-47.56-35.80-2.03
Net Margin-34.33-34.36-29.76-33.59-36.30-47.99-35.24-2.16
Shares Outstanding40.0539.5338.5738.4738.4337.7834.4434.38
Market Capitalization50.3040.1826.0234.9833.7277.71165.37214.10

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments18.3924.878.875.3515.5212.244.476.5412.96
Short Term Receivables4.103.832.381.901.960.920.420.380.30
Inventories3.123.171.801.400.810.710.440.260.20
Other Current Assets1.940.930.600.570.890.570.820.700.39
Total Current Assets27.5632.7913.659.2219.1914.456.157.8713.85
Net Property, Plant & Equipment8.898.910.840.700.910.260.150.190.08
Total Investments and Advances0.570.380.000.130.000.000.070.070.05
Intangible Assets1.59---0.000.000.000.000.00
Deferred Tax Assets1.68--------
Other Assets0.020.160.090.110.000.000.220.140.00
Total Assets40.3142.2414.5810.1620.1014.716.608.2813.97
Short Term Debt Incl. Current Port. of LT Debt0.490.750.490.350.330.021.760.000.00
Accounts Payable1.511.171.070.570.720.180.450.430.26
Income Tax Payable0.810.320.100.050.110.12---
Other Current Liabilities5.537.943.822.633.112.551.671.431.22
Total Current Liabilities8.3510.175.483.604.282.873.881.861.49
Long Term Debt18.897.360.120.200.400.160.890.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities1.68--------
Other Liabilities0.000.000.000.000.000.120.000.000.04
Total Liabilities28.9117.535.593.804.693.144.771.861.53
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity11.4024.718.996.3615.4111.571.826.4312.45
Total Shareholders Equity11.4024.718.996.3615.4111.571.826.4312.45
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity11.4024.718.996.3615.4111.571.826.4312.45
Total Liabilities & Stockholders Equity40.3142.2414.5810.1620.1014.716.608.2813.97
Book Value Per Share0.300.720.330.822.242.523.1815.4833.52
Tangible Book Value Per Share0.260.720.330.822.242.523.1815.4833.52
Full-Time Employees1951851061008764504622
Price to Book Ratio18.4920.9612.050.463.052.672.842.798.89
Return on Assets-37.73-21.76-65.86-70.87-59.60-108.54-143.99-92.71-
Return on Equity-86.24-36.69-106.17-98.50-76.90-172.72-259.69-109.34-
Return on Invested Capital-51.41-19.28-89.49-163.44-65.60-98.66-394.78-160.55-97.20
Quick Ratio2.932.912.162.174.294.791.474.119.19
Current Ratio3.303.222.492.564.485.031.584.249.32

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-15.08-15.57-6.18-8.15-10.72-10.37-11.56-10.71-10.32
Depreciation2.081.760.780.520.540.340.110.100.07
Other Funds (Non Cash)7.133.150.861.161.391.081.570.830.83
Funds from Operations-5.86-10.65-4.55-6.47-8.78-8.96-9.88-9.79-9.42
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-0.73-3.861.260.29-1.45-0.590.85-0.55-0.19
Income Taxes Payable0.540.440.24-0.05-----
Cash from Operating Activities-6.59-14.51-3.29-6.17-10.23-9.55-9.03-10.34-9.61
Capital Expenditures-1.00-3.33-1.36-0.15-0.11-0.33-0.05-0.05-0.13
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments-0.74-3.721.62-1.88-0.200.000.000.000.00
Purchase of Investments-4.24-5.47-5.98-5.88-0.200.000.000.000.00
Sale Or Maturity of Investments3.501.747.604.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-1.75-7.060.26-2.03-0.31-0.33-0.05-0.05-0.13
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.000.0021.139.720.0013.1718.725.603.41
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.000.0021.139.720.0013.1718.725.603.41
Proceedsfrom Stock Options0.000.0020.379.720.001.1018.555.60-0.14
Issuance or Reduction of Debt, Net7.4311.430.000.000.000.00-1.962.790.00
Change in Long Term Debt7.4311.430.000.000.000.00-1.962.790.00
Issuance of Long Term Debt11.6415.640.000.000.000.000.002.790.00
Reduction of Long Term Debt-4.21-4.210.000.000.000.00-1.960.000.00
Net Financing Active Other Cash Flow-0.280.00-0.20-0.010.380.000.02-0.07-0.07
Other Financing Activities Uses-0.280.00-0.20-0.010.000.00-0.00-0.08-0.07
Cash from Financing Activities7.1411.4320.939.710.3813.1716.788.323.34
Exchange Rate Effect-0.060.10-0.030.01-0.01-0.01-0.000.00-
Net Change in Cash-1.25-10.0417.881.53-10.183.287.70-2.08-6.40
Free Cash Flow-5.76-16.25-4.65-6.32-10.35-9.87-9.08-10.39-9.73
Preferred Dividends (Cash Flow)-0.000.000.000.00--0.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments11.9513.4515.7018.3912.5515.48
Short Term Receivables5.924.954.824.105.297.05
Inventories3.103.173.553.123.654.13
Other Current Assets2.532.961.591.941.461.38
Total Current Assets23.5024.5325.6627.5622.9528.04
Net Property, Plant & Equipment8.068.508.748.8910.599.97
Total Investments and Advances0.570.570.570.570.380.38
Intangible Assets1.651.721.761.59--
Deferred Tax Assets---1.68--
Other Assets0.020.020.020.020.170.29
Total Assets33.8035.3436.7540.3134.0838.67
Short Term Debt Incl. Current Port. of LT Debt2.621.180.590.492.053.13
Accounts Payable1.111.251.811.511.622.51
Income Tax Payable0.880.590.860.810.350.20
Other Current Liabilities7.667.606.115.535.185.91
Total Current Liabilities12.2710.619.398.359.2011.75
Long Term Debt18.7818.9018.3718.8910.259.30
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---1.68--
Other Liabilities0.000.000.000.000.000.00
Total Liabilities31.0529.5127.7528.9119.4521.06
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity2.755.839.0011.4014.6317.62
Total Shareholders Equity2.755.839.0011.4014.6317.62
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity2.755.839.0011.4014.6317.62
Total Liabilities & Stockholders Equity33.8035.3436.7540.3134.0838.67
Book Value Per Share0.070.150.230.300.380.47
Tangible Book Value Per Share0.030.100.190.260.380.47
Full-Time Employees---195--
Price to Book Ratio18.497.052.892.391.913.43
Return on Assets-44.42-39.20-38.95-37.73-47.71-33.99
Return on Equity-173.54-123.76-98.53-86.24-100.51-68.32
Return on Invested Capital-19.66-16.26-11.00-12.59-14.73-17.21
Quick Ratio1.662.012.362.932.102.03
Current Ratio1.922.312.733.302.492.39

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-4.23-4.02-3.01-3.81-3.66-4.63
Depreciation0.590.570.470.450.430.43
Other Funds (Non Cash)3.252.540.011.330.890.36
Funds from Operations-0.39-0.91-2.53-2.03-2.34-3.85
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.92-1.030.330.890.51-5.02
Income Taxes Payable0.30-0.280.070.440.14-0.14
Cash from Operating Activities-1.31-1.94-2.20-1.14-1.83-8.87
Capital Expenditures-0.08-0.08-0.49-0.35-1.05-1.26
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments1.402.100.00-4.241.240.50
Purchase of Investments0.000.000.00-4.240.000.00
Sale Or Maturity of Investments1.402.100.000.001.240.50
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities1.322.02-0.49-4.590.19-0.76
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.007.430.004.00
Change in Long Term Debt0.000.000.007.430.004.00
Issuance of Long Term Debt0.000.000.0011.640.004.00
Reduction of Long Term Debt0.000.000.00-4.210.000.00
Net Financing Active Other Cash Flow-0.13-0.240.000.09-0.050.00
Other Financing Activities Uses-0.13-0.240.000.09-0.050.00
Cash from Financing Activities-0.13-0.240.007.51-0.054.00
Exchange Rate Effect-0.01-0.01-0.04-0.000.000.07
Net Change in Cash-0.12-0.18-2.741.78-1.69-5.55
Free Cash Flow-1.36-1.98-2.530.10-2.88-10.12

Revenue breakdown

Product2024: 32.55M
Total Orthopedic, Prosthetic & Surgical Appliances & Supplies revenue2025: 40.93M
Germany2024: 4.23M
Other International Locations2024: 325.51K
United States2024: 27.99M 2025: 40.93M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.26%1.2M35.5M468.76K
2026-10-153.00%1.1M35.5M490.37K
2026-09-302.97%1.1M35.9M505.17K
2026-09-153.33%1.2M35.9M675.04K
2026-08-313.33%1.2M35.8M875.02K
2026-08-143.14%1.1M35.8M859.21K
2026-07-315.12%1.8M36.1M782.64K
2026-07-156.85%2.4M35.2M783.75K
2026-06-306.90%2.4M35.4M764.30K
2026-06-159.25%3.3M35.8M572.14K
2026-05-299.62%3.4M35.8M398.72K
2026-05-1510.75%3.8M35.5M372.76K
2026-04-3010.81%3.8M35.5M361.26K
2026-04-1510.99%3.9M35.4M412.16K
2026-03-3110.62%3.8M35.7M469.05K
2026-03-1313.71%4.9M35.7M529.88K
2026-02-2712.89%4.6M35.6M592.11K
2026-02-1313.39%4.8M35.6M637.11K
2026-01-3013.26%4.7M35.6M718.20K
2026-01-159.59%3.4M35.6M836.82K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.500.000.150.054.8734650.000.327-0.0190.001
call5.000.000.050.055.29771.000.000.126-0.0120.000
call7.500.000.750.046.4994.000.000.113-0.0140.000
put2.500.801.550.007.6010.000.00-0.674-0.0200.001
put5.003.204.200.0011.6230.000.00-0.873-0.0120.000
put7.505.706.700.0012.9580.000.00-0.886-0.0130.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-098-KCurrent report2026-11-09SEC
2026-10-154Statement of changes in beneficial ownership of securities2026-10-13SEC
2026-10-154/A2026-09-11SEC
2026-10-154Statement of changes in beneficial ownership of securities2026-10-13SEC
2026-10-154Statement of changes in beneficial ownership of securities2026-10-13SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-09SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-09SEC
2026-10-13144Filing for proposed sale of securities under Rule 144.SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-12SEC
2026-10-133Initial statement of beneficial ownership of securities2026-10-12SEC
2026-10-13S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-11SEC
2026-09-11144Filing for proposed sale of securities under Rule 144.SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-08-244/A2026-08-20SEC
2026-08-214Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-20144Filing for proposed sale of securities under Rule 144.SEC
2026-08-12SCHEDULE 13G/ASEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-07SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-07SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-07SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-07SEC
2026-08-05S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-058-KCurrent report2026-08-05SEC
2026-07-134Statement of changes in beneficial ownership of securities2026-07-10SEC
2026-07-134Statement of changes in beneficial ownership of securities2026-07-10SEC
2026-07-13144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090040.83K2
2026-080029.90K1
2026-070000
2026-0650.80K100
2026-05266.98K532.24K2
2026-040000
2026-03116.04K300
2026-020000
2026-010000
2025-120000
2025-118.59K400

Institutional holders

Manager% owned
Rosalind Advisors, Inc.9.42%
VANGUARD CAPITAL MANAGEMENT LLC4.24%
AQR CAPITAL MANAGEMENT LLC2.40%
Jefferies Financial Group Inc.1.82%
JANE STREET GROUP, LLC1.54%
Clearstead Advisors, LLC1.07%
GEODE CAPITAL MANAGEMENT, LLC0.88%
Palumbo Wealth Management LLC0.78%
GSA CAPITAL PARTNERS LLP0.70%
MILLENNIUM MANAGEMENT LLC0.70%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND3.22%
VANGUARD EXTENDED MARKET INDEX FUND0.96%
Fidelity Small Cap Index Fund0.92%
VANGUARD RUSSELL 2000 INDEX FUND0.47%
Fidelity Extended Market Index Fund0.44%
Schwab Small-Cap Index Fund0.21%
Fidelity Total Market Index Fund0.13%
Fidelity Series Total Market Index Fund0.12%
Nuveen Small Cap Blend Index Fund0.11%
VANGUARD RUSSELL 2000 GROWTH INDEX FUND0.08%

OakChart. MYO. Cached 15 minutes.